PUMD — ProUroCare Medical Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $2.31m
Annual income statement for ProUroCare Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 2.75 | 4.37 | 3.29 | 1.94 | 2.71 |
| Operating Profit | -2.75 | -4.37 | -3.29 | -1.94 | -2.71 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -4.66 | -6.94 | -6.02 | -2.06 | -2.96 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -2.58 | -0.682 | -0.357 | -0.103 | -0.129 |
| Dividends per Share |